{
    "clinical_study": {
        "@rank": "159838", 
        "acronym": "IVIS", 
        "arm_group": [
            {
                "arm_group_label": "IV Fluid", 
                "arm_group_type": "Experimental", 
                "description": "0.9% NaCl solution infusion: 100 ml/hr for three days."
            }, 
            {
                "arm_group_label": "No IV Fluid", 
                "arm_group_type": "No Intervention", 
                "description": "Not receive any intravenous fluid but can consume oral fluid normally for three days."
            }
        ], 
        "brief_summary": {
            "textblock": "To study the result of intravenous fluid in patients with acute ischemic stroke within 72\n      hours."
        }, 
        "brief_title": "Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Ischemic Stroke", 
        "condition_browse": {
            "mesh_term": [
                "Ischemia", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study aims to find the effect of early  IV fluid administration  to patients with acute\n      ischemic stroke on the neurological outcome and to determine the side effects of intravenous\n      fluids. Due to its cost effectiveness and wide accessibility, the possible application or\n      use of IV fluid infusion as first line treatment can aide in the treatment of more acute\n      ischemic stroke patients worldwide.  This novel information will aide physicians with more\n      comprehensive understanding of the efficacy of utilizing IV fluid in future treatment plans\n      for patients with acute ischemic stroke."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age from 18-80 years\n\n          2. NIHSS \u2265 1\n\n          3. Diagnosis of acute ischemic stroke within 72 hours from stroke onset\n\n          4. Enrollment into the study within 24 hours after hospital arrival\n\n          5. Urine specific gravity level < 1.030\n\n          6. Patient consent\n\n        Exclusion Criteria:\n\n          1. Patients receiving > 40 ml/hr IV fluid infusion over 3 hours\n\n          2. Acute ischemic stroke caused cardiogenic embolism\n\n          3. Urine specific gravity \u2265 1.030\n\n          4. Large cerebral infarction area\n\n               1. Infarction > 1/3 of middle cerebral artery area\n\n               2. Infarction > 1/2 of cerebellar hemisphere\n\n          5. NHISS \u2265 18\n\n          6. Previous or current episode of atrial fibrillation\n\n          7. Previous or current episode congestive heart failure\n\n          8. Previous echocardiogram with ejection fraction < 40%\n\n          9. Previous or current episode of dilated cardiomyopathy\n\n         10. Abnormal renal function GFR \u2264 60% or serum creatinine \u2265 2\n\n         11. Modified Rankin scale before acute ischemic stroke \u2265 2\n\n         12. Patients receiving intravenous thrombolysis\n\n         13. NPO with need for IV fluid\n\n         14. IV fluid infusion needed from any other causes\n\n         15. Patients with poor prognosis with life expectancy < 90 days\n\n         16. Patients involved in other ongoing clinical studies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003794", 
            "org_study_id": "IVIS 001"
        }, 
        "intervention": {
            "arm_group_label": "IV Fluid", 
            "description": "0.9% NaCl solution intravenous infusion: 100 ml/hr for three days.", 
            "intervention_name": "0.9% NaCl solution", 
            "intervention_type": "Drug", 
            "other_name": "Normal saline"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "acute ischemic stroke", 
            "intravenous fluid", 
            "\u0e49hydration"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "location": {
            "contact": {
                "email": "fern2_95@yahoo.com", 
                "last_name": "Supparat Charnwut, RN", 
                "phone": "6622564655"
            }, 
            "contact_backup": {
                "email": "aurauma@yahoo.com", 
                "last_name": "Aurauma Chutinet, MD", 
                "phone": "6622564655"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10330"
                }, 
                "name": "Chulalongkorn University"
            }, 
            "investigator": {
                "last_name": "Nijasri C Suwanwela, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)", 
        "overall_contact": {
            "email": "fern2_95@yahoo.com", 
            "last_name": "Supparat Charnwut, RN", 
            "phone": "6622564655"
        }, 
        "overall_contact_backup": {
            "email": "aurauma@yahoo.com", 
            "last_name": "Aurauma Chutinet, MD", 
            "phone": "6622564655"
        }, 
        "overall_official": {
            "affiliation": "Chulalongkorn University", 
            "last_name": "Nijasri C Suwanwela, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients with good outcome by NIHSS \u2264 4 at day 7 after treatment or on the day of discharge, which ever comes first.", 
            "measure": "NIHSS \u2264 4", 
            "safety_issue": "No", 
            "time_frame": "day 7 after treatment or on the day of discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003794"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chulalongkorn University", 
            "investigator_full_name": "Nijasri C Suwanwela", 
            "investigator_title": "Division of Neurology, Department of Medicine, Faculty of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients with mRS \u2264 1 at day 7 after treatment or on the day of discharge, which ever comes first.", 
                "measure": "mRS \u2264 1", 
                "safety_issue": "No", 
                "time_frame": "day 7 after treatment or on the day of discharge"
            }, 
            {
                "description": "Patients with mRS \u2264 4 at day 90", 
                "measure": "mRS \u2264 4", 
                "safety_issue": "No", 
                "time_frame": "at day 90"
            }, 
            {
                "description": "Patients with mRS \u2264 1 at day 90", 
                "measure": "mRS \u2264 1", 
                "safety_issue": "No", 
                "time_frame": "at day 90"
            }, 
            {
                "description": "Percentage of change of serum osmolarity at day 3 after treatment", 
                "measure": "change of serum osmolarity", 
                "safety_issue": "No", 
                "time_frame": "at day 3 after treatment"
            }
        ], 
        "source": "Chulalongkorn University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Research Council of Thailand (NRCT)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Chulalongkorn University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}